About
KiloGen Therapeutics develops a molecular glue therapeutics platform that combines AI, physics, and chemistry to target hard-to-drug oncology targets.
Explore KiloGen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.